Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 in children with haematological malignancies.
Millen GC, Arnold R, Cazier JB, Curley H, Feltbower R, Gamble A, Glaser A, Grundy RG, Kirton L, Lee LYW, McCabe MG, Palles C, Phillips B, Stiller CA, Varnai C, Kearns P. Millen GC, et al. Among authors: kearns p. Arch Dis Child. 2022 Feb;107(2):186-188. doi: 10.1136/archdischild-2021-322062. Epub 2021 Jul 22. Arch Dis Child. 2022. PMID: 34301621 Free PMC article.
The role of high-dose myeloablative chemotherapy with haematopoietic stem cell transplantation (HSCT) in children with central nervous system (CNS) tumours: protocol for a systematic review and meta-analysis.
Main C, Wilson JS, Stevens SP, Houlton AE, English M, Kearns PR, Phillips B, Pizer B, Wilne S, Wheatley K. Main C, et al. Among authors: kearns pr. Syst Rev. 2015 Nov 20;4:168. doi: 10.1186/s13643-015-0155-7. Syst Rev. 2015. PMID: 26589619 Free PMC article.
The utility of routine surveillance screening with magnetic resonance imaging to detect tumor recurrence/progression in children with high-grade central nervous system tumors: a systematic review.
Stevens SP, Main C, Bailey S, Pizer B, English M, Phillips B, Peet A, Avula S, Wilne S, Wheatley K, Kearns PR, Wilson JS. Stevens SP, et al. Among authors: kearns pr. Pediatr Blood Cancer. 2019 Feb;66(2):e27509. doi: 10.1002/pbc.27509. Epub 2018 Nov 8. Pediatr Blood Cancer. 2019. PMID: 30408313 Free article.
The Care of Children With Cancer During the COVID-19 Pandemic.
Moreira DC, Millen GC, Sands S, Kearns PR, Hawkins DS. Moreira DC, et al. Am Soc Clin Oncol Educ Book. 2021 Mar;41:1-10. doi: 10.1200/EDBK_321497. Am Soc Clin Oncol Educ Book. 2021. PMID: 33989020 Free article. Review.
CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults.
Veenith T, Fisher BA, Slade D, Rowe A, Sharpe R, Thickett DR, Whitehouse T, Rowland M, Scriven J, Parekh D, Bowden SJ, Savage JS, Richards D, Bion J, Kearns P, Gates S; CATALYST Trial Investigators; CATALYST investigators. Veenith T, et al. Among authors: kearns p. BMJ Open. 2021 Nov 11;11(11):e050202. doi: 10.1136/bmjopen-2021-050202. BMJ Open. 2021. PMID: 34764169 Free PMC article.
Impact of Tumour Epstein-Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial Cohort of Children with cHL.
Nohtani M, Vrzalikova K, Ibrahim M, Powell JE, Fennell É, Morgan S, Grundy R, McCarthy K, Dewberry S, Bouchal J, Bouchalova K, Kearns P, Murray PG. Nohtani M, et al. Among authors: kearns p. Cancers (Basel). 2022 Sep 1;14(17):4297. doi: 10.3390/cancers14174297. Cancers (Basel). 2022. PMID: 36077832 Free PMC article.
Pediatric cancer research: Surviving COVID-19.
Auletta JJ, Adamson PC, Agin JE, Kearns P, Kennedy S, Kieran MW, Ludwinski DM, Knox LJ, McKay K, Rhiner P, Thiele CJ, Cripe TP. Auletta JJ, et al. Among authors: kearns p. Pediatr Blood Cancer. 2020 Sep;67(9):e28435. doi: 10.1002/pbc.28435. Epub 2020 Jun 18. Pediatr Blood Cancer. 2020. PMID: 32558190 Free PMC article. Review.
Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial.
Fisher BA, Veenith T, Slade D, Gaskell C, Rowland M, Whitehouse T, Scriven J, Parekh D, Balasubramaniam MS, Cooke G, Morley N, Gabriel Z, Wise MP, Porter J, McShane H, Ho LP, Newsome PN, Rowe A, Sharpe R, Thickett DR, Bion J, Gates S, Richards D, Kearns P; CATALYST investigators. Fisher BA, et al. Among authors: kearns p. Lancet Respir Med. 2022 Mar;10(3):255-266. doi: 10.1016/S2213-2600(21)00460-4. Epub 2021 Dec 16. Lancet Respir Med. 2022. PMID: 34922649 Free PMC article. Clinical Trial.
311 results